|
Market Closed -
Nasdaq
00:00:00 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 16.75 USD | -4.72% |
|
-12.58% | -45.03% |
| 10-28 | Beta Bionics, Inc., Q3 2026 Earnings Call, Oct 27, 2026 | |
| 10-28 | Earnings Flash (BBNX) Beta Bionics Posts Q3 Per-Share Loss $0.52, vs. FactSet Est of $0.52 Loss | MT |
Company Valuation: Beta Bionics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 1,341 | 910.6 | - | - |
| Change | - | -32.11% | - | - |
| Enterprise Value (EV) 1 | 1,130 | 691.8 | 808.1 | 851.7 |
| Change | - | -38.75% | 16.81% | 5.39% |
| P/E | -16.8x | -8.16x | -7.86x | -10.4x |
| PBR | 4.7x | 2.37x | 2.99x | 3.26x |
| PEG | 0.2x | -0.6x | -2.06x | 0.4x |
| Capitalization / Revenue | 13.4x | 7.25x | 4.91x | 3.2x |
| EV / Revenue | 11.3x | 5.51x | 4.36x | 2.99x |
| EV / EBITDA | -21.4x | -9.04x | -9.89x | -18.4x |
| EV / EBIT | -15.8x | -6.56x | -6.61x | -8.52x |
| EV / FCF | -20.1x | -7.47x | -6.74x | -12.8x |
| FCF Yield | -4.98% | -13.4% | -14.8% | -7.83% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -1.81 | -2.052 | -2.13 | -1.605 |
| Distribution rate | - | - | - | - |
| Net sales 1 | 100.3 | 125.6 | 185.5 | 284.7 |
| EBITDA 1 | -52.75 | -76.49 | -81.74 | -46.25 |
| EBIT 1 | -71.68 | -105.5 | -122.2 | -99.97 |
| Net income 1 | -73.2 | -96.24 | -113 | -83.54 |
| Net Debt 1 | -211.9 | -218.8 | -102.5 | -58.95 |
| Reference price 2 | 30.47 | 16.75 | 16.75 | 16.75 |
| Nbr of stocks (in thousands) | 44,025 | 54,367 | - | - |
| Announcement Date | 17/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.16x | 5.51x | -9.04x | -.--% | 911M | |
| 35.69x | 6.07x | 23.2x | 0.27% | 258B | |
| 36.92x | 7x | 21.93x | 0.62% | 163B | |
| 49.76x | 12.05x | 25.86x | -.--% | 150B | |
| 17x | 3.45x | 11.22x | -.--% | 60.84B | |
| 36.47x | 7.31x | 23.11x | -.--% | 53.03B | |
| 21x | 2.51x | 12.66x | 2.4% | 53.31B | |
| 34.07x | 6.75x | 22.92x | 0.59% | 49.3B | |
| 47.92x | 11.82x | 26.05x | -.--% | 50.67B | |
| 81x | 7.7x | 23.37x | -.--% | 45.46B | |
| Average | 35.17x | 7.02x | 18.13x | 0.39% | 88.44B | |
| Weighted average by Cap. | 39.07x | 7.39x | 22.08x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BBNX Stock
- Valuation Beta Bionics, Inc.
Select your edition
All financial news and data tailored to specific country editions
